AustralieFrV1, PubMed, Corpus, bibRecord, 003352

Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.

Identifieur interne : 003352 ( PubMed/Corpus ); précédent : 003351; suivant : 003353

Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.

Auteurs : L. Alemany ; M. Saunier ; L. Tinoco ; B. Quir S ; I. Alvarado-Cabrero ; M. Alejo ; E A Joura ; P. Maldonado ; J. Klaustermeier ; J. Salmer N ; C. Bergeron ; K U Petry ; N. Guimerà ; O. Clavero ; R. Murillo ; C. Clavel ; V. Wain ; D T Geraets ; R. Jach ; P. Cross ; C. Carrilho ; C. Molina ; H R Shin ; V. Mandys ; A M Nowakowski ; A. Vidal ; L. Lombardi ; H. Kitchener ; A R Sica ; C. Maga A-Le N ; M. Pawlita ; W. Quint ; I G Bravo ; N. Mu Oz ; S. De Sanjosé ; F X Bosch

Source :

European journal of cancer (Oxford, England : 1990) [ 1879-0852 ] ; 2014.

RBID : pubmed:25155250

English descriptors

KwdEn :
- Aged, Carcinoma, Squamous Cell (complications), Carcinoma, Squamous Cell (epidemiology), Carcinoma, Squamous Cell (virology), Cross-Sectional Studies, Cyclin-Dependent Kinase Inhibitor p16 (metabolism), DNA, Viral (analysis), Female, Human papillomavirus 16 (isolation & purification), Humans, Immunoenzyme Techniques, International Cooperation, Middle Aged, Papillomaviridae (isolation & purification), Papillomavirus Infections (complications), Papillomavirus Infections (epidemiology), Papillomavirus Infections (virology), Poisson Distribution, Precancerous Conditions (epidemiology), Precancerous Conditions (virology), Prevalence, Regression Analysis, Retrospective Studies, Treatment Outcome, Vaginal Neoplasms (complications), Vaginal Neoplasms (epidemiology), Vaginal Neoplasms (virology).
MESH :
- chemical , analysis : DNA, Viral.
- chemical , metabolism : Cyclin-Dependent Kinase Inhibitor p16.
- complications : Carcinoma, Squamous Cell, Papillomavirus Infections, Vaginal Neoplasms.
- epidemiology : Carcinoma, Squamous Cell, Papillomavirus Infections, Precancerous Conditions, Vaginal Neoplasms.
- isolation & purification : Human papillomavirus 16, Papillomaviridae.
- virology : Carcinoma, Squamous Cell, Papillomavirus Infections, Precancerous Conditions, Vaginal Neoplasms.
- Aged, Cross-Sectional Studies, Female, Humans, Immunoenzyme Techniques, International Cooperation, Middle Aged, Poisson Distribution, Prevalence, Regression Analysis, Retrospective Studies, Treatment Outcome.

Abstract

This work describes the human papillomavirus (HPV) prevalence and the HPV type distribution in a large series of vaginal intraepithelial neoplasia (VAIN) grades 2/3 and vaginal cancer worldwide.

DOI: 10.1016/j.ejca.2014.07.018
PubMed: 25155250

Links to Exploration step

pubmed:25155250

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.</title>
<author><name sortKey="Alemany, L" sort="Alemany, L" uniqKey="Alemany L" first="L" last="Alemany">L. Alemany</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain. Electronic address: lalemany@iconcologia.net.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Saunier, M" sort="Saunier, M" uniqKey="Saunier M" first="M" last="Saunier">M. Saunier</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tinoco, L" sort="Tinoco, L" uniqKey="Tinoco L" first="L" last="Tinoco">L. Tinoco</name>
<affiliation><nlm:affiliation>Hospital Oncológico, Quito, Ecuador.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Quir S, B" sort="Quir S, B" uniqKey="Quir S B" first="B" last="Quir S">B. Quir S</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Alvarado Cabrero, I" sort="Alvarado Cabrero, I" uniqKey="Alvarado Cabrero I" first="I" last="Alvarado-Cabrero">I. Alvarado-Cabrero</name>
<affiliation><nlm:affiliation>Mexican Oncology Hospital, IMSS, Mexico, DF, Mexico.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Alejo, M" sort="Alejo, M" uniqKey="Alejo M" first="M" last="Alejo">M. Alejo</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Hospital General de L'Hospitalet, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Joura, E A" sort="Joura, E A" uniqKey="Joura E" first="E A" last="Joura">E A Joura</name>
<affiliation><nlm:affiliation>Department of Gynaecology and Obstetrics, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Maldonado, P" sort="Maldonado, P" uniqKey="Maldonado P" first="P" last="Maldonado">P. Maldonado</name>
<affiliation><nlm:affiliation>Instituto de Ginecologia da Universidad Federal Do Rio de Janeiro-UFRJ, Rio de Janeiro, Brazil.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Klaustermeier, J" sort="Klaustermeier, J" uniqKey="Klaustermeier J" first="J" last="Klaustermeier">J. Klaustermeier</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Salmer N, J" sort="Salmer N, J" uniqKey="Salmer N J" first="J" last="Salmer N">J. Salmer N</name>
<affiliation><nlm:affiliation>Mexican Oncology Hospital, IMSS, Mexico, DF, Mexico.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bergeron, C" sort="Bergeron, C" uniqKey="Bergeron C" first="C" last="Bergeron">C. Bergeron</name>
<affiliation><nlm:affiliation>Laboratoire Cerba, Department de Pathologie, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Petry, K U" sort="Petry, K U" uniqKey="Petry K" first="K U" last="Petry">K U Petry</name>
<affiliation><nlm:affiliation>Klinikum Wolfsburg, Wolfsburg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Guimera, N" sort="Guimera, N" uniqKey="Guimera N" first="N" last="Guimerà">N. Guimerà</name>
<affiliation><nlm:affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Clavero, O" sort="Clavero, O" uniqKey="Clavero O" first="O" last="Clavero">O. Clavero</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Murillo, R" sort="Murillo, R" uniqKey="Murillo R" first="R" last="Murillo">R. Murillo</name>
<affiliation><nlm:affiliation>Instituto Nacional de Cancerología, Bogotá, Colombia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Clavel, C" sort="Clavel, C" uniqKey="Clavel C" first="C" last="Clavel">C. Clavel</name>
<affiliation><nlm:affiliation>CHU Reims, Hopital Maison Blanche, Laboratoire Pol Bouin, Reims, France; INSERM UMR-S903, Reims, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wain, V" sort="Wain, V" uniqKey="Wain V" first="V" last="Wain">V. Wain</name>
<affiliation><nlm:affiliation>WestMead Hospital, Sydney, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Geraets, D T" sort="Geraets, D T" uniqKey="Geraets D" first="D T" last="Geraets">D T Geraets</name>
<affiliation><nlm:affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jach, R" sort="Jach, R" uniqKey="Jach R" first="R" last="Jach">R. Jach</name>
<affiliation><nlm:affiliation>Jagiellonian University Medical College, Krakow, Poland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cross, P" sort="Cross, P" uniqKey="Cross P" first="P" last="Cross">P. Cross</name>
<affiliation><nlm:affiliation>Queen Elizabeth Hospital, Sheriff Hill, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Carrilho, C" sort="Carrilho, C" uniqKey="Carrilho C" first="C" last="Carrilho">C. Carrilho</name>
<affiliation><nlm:affiliation>Faculty of Medicine, Eduardo Mondlane University and Maputo Central Hospital, Maputo, Mozambique.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Molina, C" sort="Molina, C" uniqKey="Molina C" first="C" last="Molina">C. Molina</name>
<affiliation><nlm:affiliation>Centro de Oncología Preventiva, Universidad de Chile, Santiago, Chile.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Shin, H R" sort="Shin, H R" uniqKey="Shin H" first="H R" last="Shin">H R Shin</name>
<affiliation><nlm:affiliation>National Cancer Center, Seoul, South Korea.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mandys, V" sort="Mandys, V" uniqKey="Mandys V" first="V" last="Mandys">V. Mandys</name>
<affiliation><nlm:affiliation>Third Faculty of Medicine and Faculty Hospital King's Wineyards, Prague, Czech Republic.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Nowakowski, A M" sort="Nowakowski, A M" uniqKey="Nowakowski A" first="A M" last="Nowakowski">A M Nowakowski</name>
<affiliation><nlm:affiliation>Medical University of Lublin, Lublin, Poland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Vidal, A" sort="Vidal, A" uniqKey="Vidal A" first="A" last="Vidal">A. Vidal</name>
<affiliation><nlm:affiliation>Hospital Universitari de Bellvitge, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lombardi, L" sort="Lombardi, L" uniqKey="Lombardi L" first="L" last="Lombardi">L. Lombardi</name>
<affiliation><nlm:affiliation>Centro de Investigación Epidemiológica en Salud Sexual y Reproductiva - CIESAR, Hospital General San Juan de Dios - HGSJDD, Guatemala, Guatemala.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kitchener, H" sort="Kitchener, H" uniqKey="Kitchener H" first="H" last="Kitchener">H. Kitchener</name>
<affiliation><nlm:affiliation>Manchester Royal Infirmary, Manchester, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sica, A R" sort="Sica, A R" uniqKey="Sica A" first="A R" last="Sica">A R Sica</name>
<affiliation><nlm:affiliation>Laboratorio de Anatomia Patológica del Hospital de la Mujer, Montevideo, Uruguay.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Maga A Le N, C" sort="Maga A Le N, C" uniqKey="Maga A Le N C" first="C" last="Maga A-Le N">C. Maga A-Le N</name>
<affiliation><nlm:affiliation>Instituto Potosino de Investigación Científica y Tecnológica, AC (IPICYT), San Luis Potosí, Mexico.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pawlita, M" sort="Pawlita, M" uniqKey="Pawlita M" first="M" last="Pawlita">M. Pawlita</name>
<affiliation><nlm:affiliation>German Cancer Research Center (DKFZ), Heidelberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Quint, W" sort="Quint, W" uniqKey="Quint W" first="W" last="Quint">W. Quint</name>
<affiliation><nlm:affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bravo, I G" sort="Bravo, I G" uniqKey="Bravo I" first="I G" last="Bravo">I G Bravo</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mu Oz, N" sort="Mu Oz, N" uniqKey="Mu Oz N" first="N" last="Mu Oz">N. Mu Oz</name>
<affiliation><nlm:affiliation>Cancer Institute of Colombia, Colombia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="De Sanjose, S" sort="De Sanjose, S" uniqKey="De Sanjose S" first="S" last="De Sanjosé">S. De Sanjosé</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bosch, F X" sort="Bosch, F X" uniqKey="Bosch F" first="F X" last="Bosch">F X Bosch</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25155250</idno>
<idno type="pmid">25155250</idno>
<idno type="doi">10.1016/j.ejca.2014.07.018</idno>
<idno type="wicri:Area/PubMed/Corpus">003352</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003352</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.</title>
<author><name sortKey="Alemany, L" sort="Alemany, L" uniqKey="Alemany L" first="L" last="Alemany">L. Alemany</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain. Electronic address: lalemany@iconcologia.net.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Saunier, M" sort="Saunier, M" uniqKey="Saunier M" first="M" last="Saunier">M. Saunier</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tinoco, L" sort="Tinoco, L" uniqKey="Tinoco L" first="L" last="Tinoco">L. Tinoco</name>
<affiliation><nlm:affiliation>Hospital Oncológico, Quito, Ecuador.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Quir S, B" sort="Quir S, B" uniqKey="Quir S B" first="B" last="Quir S">B. Quir S</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Alvarado Cabrero, I" sort="Alvarado Cabrero, I" uniqKey="Alvarado Cabrero I" first="I" last="Alvarado-Cabrero">I. Alvarado-Cabrero</name>
<affiliation><nlm:affiliation>Mexican Oncology Hospital, IMSS, Mexico, DF, Mexico.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Alejo, M" sort="Alejo, M" uniqKey="Alejo M" first="M" last="Alejo">M. Alejo</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Hospital General de L'Hospitalet, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Joura, E A" sort="Joura, E A" uniqKey="Joura E" first="E A" last="Joura">E A Joura</name>
<affiliation><nlm:affiliation>Department of Gynaecology and Obstetrics, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Maldonado, P" sort="Maldonado, P" uniqKey="Maldonado P" first="P" last="Maldonado">P. Maldonado</name>
<affiliation><nlm:affiliation>Instituto de Ginecologia da Universidad Federal Do Rio de Janeiro-UFRJ, Rio de Janeiro, Brazil.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Klaustermeier, J" sort="Klaustermeier, J" uniqKey="Klaustermeier J" first="J" last="Klaustermeier">J. Klaustermeier</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Salmer N, J" sort="Salmer N, J" uniqKey="Salmer N J" first="J" last="Salmer N">J. Salmer N</name>
<affiliation><nlm:affiliation>Mexican Oncology Hospital, IMSS, Mexico, DF, Mexico.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bergeron, C" sort="Bergeron, C" uniqKey="Bergeron C" first="C" last="Bergeron">C. Bergeron</name>
<affiliation><nlm:affiliation>Laboratoire Cerba, Department de Pathologie, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Petry, K U" sort="Petry, K U" uniqKey="Petry K" first="K U" last="Petry">K U Petry</name>
<affiliation><nlm:affiliation>Klinikum Wolfsburg, Wolfsburg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Guimera, N" sort="Guimera, N" uniqKey="Guimera N" first="N" last="Guimerà">N. Guimerà</name>
<affiliation><nlm:affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Clavero, O" sort="Clavero, O" uniqKey="Clavero O" first="O" last="Clavero">O. Clavero</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Murillo, R" sort="Murillo, R" uniqKey="Murillo R" first="R" last="Murillo">R. Murillo</name>
<affiliation><nlm:affiliation>Instituto Nacional de Cancerología, Bogotá, Colombia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Clavel, C" sort="Clavel, C" uniqKey="Clavel C" first="C" last="Clavel">C. Clavel</name>
<affiliation><nlm:affiliation>CHU Reims, Hopital Maison Blanche, Laboratoire Pol Bouin, Reims, France; INSERM UMR-S903, Reims, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wain, V" sort="Wain, V" uniqKey="Wain V" first="V" last="Wain">V. Wain</name>
<affiliation><nlm:affiliation>WestMead Hospital, Sydney, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Geraets, D T" sort="Geraets, D T" uniqKey="Geraets D" first="D T" last="Geraets">D T Geraets</name>
<affiliation><nlm:affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jach, R" sort="Jach, R" uniqKey="Jach R" first="R" last="Jach">R. Jach</name>
<affiliation><nlm:affiliation>Jagiellonian University Medical College, Krakow, Poland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cross, P" sort="Cross, P" uniqKey="Cross P" first="P" last="Cross">P. Cross</name>
<affiliation><nlm:affiliation>Queen Elizabeth Hospital, Sheriff Hill, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Carrilho, C" sort="Carrilho, C" uniqKey="Carrilho C" first="C" last="Carrilho">C. Carrilho</name>
<affiliation><nlm:affiliation>Faculty of Medicine, Eduardo Mondlane University and Maputo Central Hospital, Maputo, Mozambique.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Molina, C" sort="Molina, C" uniqKey="Molina C" first="C" last="Molina">C. Molina</name>
<affiliation><nlm:affiliation>Centro de Oncología Preventiva, Universidad de Chile, Santiago, Chile.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Shin, H R" sort="Shin, H R" uniqKey="Shin H" first="H R" last="Shin">H R Shin</name>
<affiliation><nlm:affiliation>National Cancer Center, Seoul, South Korea.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mandys, V" sort="Mandys, V" uniqKey="Mandys V" first="V" last="Mandys">V. Mandys</name>
<affiliation><nlm:affiliation>Third Faculty of Medicine and Faculty Hospital King's Wineyards, Prague, Czech Republic.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Nowakowski, A M" sort="Nowakowski, A M" uniqKey="Nowakowski A" first="A M" last="Nowakowski">A M Nowakowski</name>
<affiliation><nlm:affiliation>Medical University of Lublin, Lublin, Poland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Vidal, A" sort="Vidal, A" uniqKey="Vidal A" first="A" last="Vidal">A. Vidal</name>
<affiliation><nlm:affiliation>Hospital Universitari de Bellvitge, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lombardi, L" sort="Lombardi, L" uniqKey="Lombardi L" first="L" last="Lombardi">L. Lombardi</name>
<affiliation><nlm:affiliation>Centro de Investigación Epidemiológica en Salud Sexual y Reproductiva - CIESAR, Hospital General San Juan de Dios - HGSJDD, Guatemala, Guatemala.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kitchener, H" sort="Kitchener, H" uniqKey="Kitchener H" first="H" last="Kitchener">H. Kitchener</name>
<affiliation><nlm:affiliation>Manchester Royal Infirmary, Manchester, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sica, A R" sort="Sica, A R" uniqKey="Sica A" first="A R" last="Sica">A R Sica</name>
<affiliation><nlm:affiliation>Laboratorio de Anatomia Patológica del Hospital de la Mujer, Montevideo, Uruguay.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Maga A Le N, C" sort="Maga A Le N, C" uniqKey="Maga A Le N C" first="C" last="Maga A-Le N">C. Maga A-Le N</name>
<affiliation><nlm:affiliation>Instituto Potosino de Investigación Científica y Tecnológica, AC (IPICYT), San Luis Potosí, Mexico.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pawlita, M" sort="Pawlita, M" uniqKey="Pawlita M" first="M" last="Pawlita">M. Pawlita</name>
<affiliation><nlm:affiliation>German Cancer Research Center (DKFZ), Heidelberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Quint, W" sort="Quint, W" uniqKey="Quint W" first="W" last="Quint">W. Quint</name>
<affiliation><nlm:affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bravo, I G" sort="Bravo, I G" uniqKey="Bravo I" first="I G" last="Bravo">I G Bravo</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mu Oz, N" sort="Mu Oz, N" uniqKey="Mu Oz N" first="N" last="Mu Oz">N. Mu Oz</name>
<affiliation><nlm:affiliation>Cancer Institute of Colombia, Colombia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="De Sanjose, S" sort="De Sanjose, S" uniqKey="De Sanjose S" first="S" last="De Sanjosé">S. De Sanjosé</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bosch, F X" sort="Bosch, F X" uniqKey="Bosch F" first="F X" last="Bosch">F X Bosch</name>
<affiliation><nlm:affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">European journal of cancer (Oxford, England : 1990)</title>
<idno type="eISSN">1879-0852</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Carcinoma, Squamous Cell (complications)</term>
<term>Carcinoma, Squamous Cell (epidemiology)</term>
<term>Carcinoma, Squamous Cell (virology)</term>
<term>Cross-Sectional Studies</term>
<term>Cyclin-Dependent Kinase Inhibitor p16 (metabolism)</term>
<term>DNA, Viral (analysis)</term>
<term>Female</term>
<term>Human papillomavirus 16 (isolation & purification)</term>
<term>Humans</term>
<term>Immunoenzyme Techniques</term>
<term>International Cooperation</term>
<term>Middle Aged</term>
<term>Papillomaviridae (isolation & purification)</term>
<term>Papillomavirus Infections (complications)</term>
<term>Papillomavirus Infections (epidemiology)</term>
<term>Papillomavirus Infections (virology)</term>
<term>Poisson Distribution</term>
<term>Precancerous Conditions (epidemiology)</term>
<term>Precancerous Conditions (virology)</term>
<term>Prevalence</term>
<term>Regression Analysis</term>
<term>Retrospective Studies</term>
<term>Treatment Outcome</term>
<term>Vaginal Neoplasms (complications)</term>
<term>Vaginal Neoplasms (epidemiology)</term>
<term>Vaginal Neoplasms (virology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>DNA, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cyclin-Dependent Kinase Inhibitor p16</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Papillomavirus Infections</term>
<term>Vaginal Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Papillomavirus Infections</term>
<term>Precancerous Conditions</term>
<term>Vaginal Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Human papillomavirus 16</term>
<term>Papillomaviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Papillomavirus Infections</term>
<term>Precancerous Conditions</term>
<term>Vaginal Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Immunoenzyme Techniques</term>
<term>International Cooperation</term>
<term>Middle Aged</term>
<term>Poisson Distribution</term>
<term>Prevalence</term>
<term>Regression Analysis</term>
<term>Retrospective Studies</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This work describes the human papillomavirus (HPV) prevalence and the HPV type distribution in a large series of vaginal intraepithelial neoplasia (VAIN) grades 2/3 and vaginal cancer worldwide.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25155250</PMID>
<DateCreated><Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>12</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0852</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>50</Volume>
<Issue>16</Issue>
<PubDate><Year>2014</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>European journal of cancer (Oxford, England : 1990)</Title>
<ISOAbbreviation>Eur. J. Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.</ArticleTitle>
<Pagination><MedlinePgn>2846-54</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejca.2014.07.018</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0959-8049(14)00870-3</ELocationID>
<Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">This work describes the human papillomavirus (HPV) prevalence and the HPV type distribution in a large series of vaginal intraepithelial neoplasia (VAIN) grades 2/3 and vaginal cancer worldwide.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We analysed 189 VAIN 2/3 and 408 invasive vaginal cancer cases collected from 31 countries from 1986 to 2011. After histopathological evaluation of sectioned formalin-fixed paraffin-embedded samples, HPV DNA detection and typing was performed using the SPF-10/DNA enzyme immunoassay (DEIA)/LiPA25 system (version 1). A subset of 146 vaginal cancers was tested for p16(INK4a) expression, a cellular surrogate marker for HPV transformation. Prevalence ratios were estimated using multivariate Poisson regression with robust variance.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">HPV DNA was detected in 74% (95% confidence interval (CI): 70-78%) of invasive cancers and in 96% (95% CI: 92-98%) of VAIN 2/3. Among cancers, the highest detection rates were observed in warty-basaloid subtype of squamous cell carcinomas, and in younger ages. Concerning the type-specific distribution, HPV16 was the most frequently type detected in both precancerous and cancerous lesions (59%). p16(INK4a) overexpression was found in 87% of HPV DNA positive vaginal cancer cases.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">HPV was identified in a large proportion of invasive vaginal cancers and in almost all VAIN 2/3. HPV16 was the most common type detected. A large impact in the reduction of the burden of vaginal neoplastic lesions is expected among vaccinated cohorts.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alemany</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain. Electronic address: lalemany@iconcologia.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Saunier</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tinoco</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Hospital Oncológico, Quito, Ecuador.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Quirós</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Alvarado-Cabrero</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Mexican Oncology Hospital, IMSS, Mexico, DF, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Alejo</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Hospital General de L'Hospitalet, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Joura</LastName>
<ForeName>E A</ForeName>
<Initials>EA</Initials>
<AffiliationInfo><Affiliation>Department of Gynaecology and Obstetrics, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Maldonado</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Instituto de Ginecologia da Universidad Federal Do Rio de Janeiro-UFRJ, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Klaustermeier</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Salmerón</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Mexican Oncology Hospital, IMSS, Mexico, DF, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bergeron</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Laboratoire Cerba, Department de Pathologie, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Petry</LastName>
<ForeName>K U</ForeName>
<Initials>KU</Initials>
<AffiliationInfo><Affiliation>Klinikum Wolfsburg, Wolfsburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Guimerà</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Clavero</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Murillo</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Instituto Nacional de Cancerología, Bogotá, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Clavel</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>CHU Reims, Hopital Maison Blanche, Laboratoire Pol Bouin, Reims, France; INSERM UMR-S903, Reims, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wain</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>WestMead Hospital, Sydney, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Geraets</LastName>
<ForeName>D T</ForeName>
<Initials>DT</Initials>
<AffiliationInfo><Affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jach</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Jagiellonian University Medical College, Krakow, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cross</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Queen Elizabeth Hospital, Sheriff Hill, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Carrilho</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Faculty of Medicine, Eduardo Mondlane University and Maputo Central Hospital, Maputo, Mozambique.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Molina</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Centro de Oncología Preventiva, Universidad de Chile, Santiago, Chile.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shin</LastName>
<ForeName>H R</ForeName>
<Initials>HR</Initials>
<AffiliationInfo><Affiliation>National Cancer Center, Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mandys</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Third Faculty of Medicine and Faculty Hospital King's Wineyards, Prague, Czech Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Nowakowski</LastName>
<ForeName>A M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo><Affiliation>Medical University of Lublin, Lublin, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vidal</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Hospital Universitari de Bellvitge, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lombardi</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Centro de Investigación Epidemiológica en Salud Sexual y Reproductiva - CIESAR, Hospital General San Juan de Dios - HGSJDD, Guatemala, Guatemala.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kitchener</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Manchester Royal Infirmary, Manchester, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sica</LastName>
<ForeName>A R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo><Affiliation>Laboratorio de Anatomia Patológica del Hospital de la Mujer, Montevideo, Uruguay.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Magaña-León</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Instituto Potosino de Investigación Científica y Tecnológica, AC (IPICYT), San Luis Potosí, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pawlita</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Quint</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
<AffiliationInfo><Affiliation>DDL Diagnostic Laboratory, Rijswijk, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bravo</LastName>
<ForeName>I G</ForeName>
<Initials>IG</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Muñoz</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Cancer Institute of Colombia, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>de Sanjosé</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bosch</LastName>
<ForeName>F X</ForeName>
<Initials>FX</Initials>
<AffiliationInfo><Affiliation>Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>HPV VVAP study group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>08</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Eur J Cancer</MedlineTA>
<NlmUniqueID>9005373</NlmUniqueID>
<ISSNLinking>0959-8049</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019941">Cyclin-Dependent Kinase Inhibitor p16</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019941" MajorTopicYN="N">Cyclin-Dependent Kinase Inhibitor p16</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D052162" MajorTopicYN="N">Human papillomavirus 16</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007124" MajorTopicYN="N">Immunoenzyme Techniques</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007391" MajorTopicYN="N">International Cooperation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D027383" MajorTopicYN="N">Papillomaviridae</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D030361" MajorTopicYN="N">Papillomavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016012" MajorTopicYN="N">Poisson Distribution</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014625" MajorTopicYN="N">Vaginal Neoplasms</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Human papillomavirus</Keyword>
<Keyword MajorTopicYN="N">Vaccine</Keyword>
<Keyword MajorTopicYN="N">Vaginal cancer</Keyword>
<Keyword MajorTopicYN="N">Vaginal intraepithelial neoplasia</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>04</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2014</Year>
<Month>07</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>07</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>8</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>8</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>12</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25155250</ArticleId>
<ArticleId IdType="pii">S0959-8049(14)00870-3</ArticleId>
<ArticleId IdType="doi">10.1016/j.ejca.2014.07.018</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003352 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003352 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:25155250
   |texte=   Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:25155250" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.

Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki